Your email has been successfully added to our mailing list.

×
0.0118549905838041 0.00753295668549906 -0.00188323917137489 -0.0235404896421846 -0.0348399246704332 -0.0150659133709981 -0.0480320150659135 -0.0404896421845574
Stock impact report

Clovis Oncology's stock soars after FDA accepts sNDA for prostate cancer treatment [MarketWatch]

Clovis Oncology, Inc. (CLVS) 
Last clovis oncology, inc. earnings: 2/24 04:05 pm Check Earnings Report
Company Research Source: MarketWatch
Clovis Oncology's stock soars after FDA accepts sNDA for prostate cancer treatment Shares of Clovis Oncology Inc. CLVS, +19.55% soared 22% in very active premarket trading Wednesday, after the biopharmaceutical company said the supplemental new drug application (sNDA) for its prostate cancer treatment Rubraca has been granted priority review status by the Food and Drug Administration. Trading volume swelled to over 2.9 million shares, compared with the full-day average of 10.7 million shares. "Recently presented data suggests that Rubraca may play a meaningful role in the treatment of patients with BRCA1/2-mutant recurrent, metastatic castrate-resistant prostate cancer, and this filing represents an important milestone for Clovis as it brings us one step closer to potentially making this valuable therapy available," said Chief Executive Patrick Mahaffy. "We are encouraged by the FDA's decision to grant priority review to the Rubraca application, which focuses on eligible patients w Show less Read more
Impact Snapshot
Event Time:
CLVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
CLVS alerts

from News Quantified
Opt-in for
CLVS alerts

from News Quantified